 "FIPB gives nod to Natco's Rs 450-cr QIP")
Hyderabad-based Natco Pharma Limited today said it has received the Foreign Investment Promotion Board (FIPB) approval to raise the limit of foreign investment in the company.
The proposal for qualified institutional placement securities were also cleared by the board, it said.
The FIPB has approved the increase of foreign investment limited to 31.5% from the present 24% level of the paid up equity capital of the company.
The board has also approved the company's proposal to issue and allotment of eligible securities to qualified institutional buyers (QIBs) to the extent of Rs 450 crore.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app